AI
TMO icon

Atria Investments’s Thermo Fisher Scientific TMO Stock Holding History

Atria Investments’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14M Sell
28,478
-3,943
-12% -$2.14M 0.16% 129
2025
Q4 		$18.8M Sell
32,421
-825
-2% -$467K 0.21% 85
2025
Q3 		$16.1M Sell
33,246
-15,333
-32% -$7.14M 0.18% 106
2025
Q2 		$19.7M Buy
48,579
+5,041
+12% +$2.11M 0.23% 79
2025
Q1 		$21.7M Sell
43,538
-90
-0.2% -$48.7K 0.28% 59
2024
Q4 		$22.7M Sell
43,628
-5,610
-11% -$3.08M 0.28% 61
2024
Q3 		$30.5M Buy
49,238
+2,433
+5% +$1.44M 0.38% 46
2024
Q2 		$25.9M Buy
46,805
+187
+0.4% +$107K 0.34% 58
2024
Q1 		$27.1M Buy
46,618
+5,200
+13% +$2.92M 0.37% 54
2023
Q4 		$22M Buy
41,418
+148
+0.4% +$71.6K 0.34% 58
2023
Q3 		$20.9M Buy
41,270
+6,576
+19% +$3.5M 0.37% 53
2023
Q2 		$18.1M Buy
34,694
+382
+1% +$206K 0.33% 59
2023
Q1 		$19.8M Buy
34,312
+936
+3% +$528K 0.37% 52
2022
Q4 		$18.4M Buy
33,376
+5,481
+20% +$2.9M 0.38% 48
2022
Q3 		$14.1M Buy
27,895
+1,012
+4% +$566K 0.31% 65
2022
Q2 		$14.6M Sell
26,883
-2,067
-7% -$1.14M 0.31% 64
2022
Q1 		$17.1M Sell
28,950
-653
-2% -$375K 0.3% 70
2021
Q4 		$19.8M Sell
29,603
-322
-1% -$201K 0.35% 59
2021
Q3 		$17.1M Buy
29,925
+1,368
+5% +$751K 0.31% 66
2021
Q2 		$14.4M Sell
28,557
-9,151
-24% -$4.32M 0.28% 71
2021
Q1 		$17.2M Buy
37,708
+3,032
+9% +$1.45M 0.38% 55
2020
Q4 		$16.2M Buy
34,676
+8,492
+32% +$3.98M 0.39% 54
2020
Q3 		$11.6M Sell
26,184
-1,133
-4% -$468K 0.35% 59
2020
Q2 		$9.9M Buy
+27,317
New +$9.16M 0.34% 68
2020
Q1 		– Sell
-19,339
Closed -$6.28M – 1135
2019
Q4 		$6.28M Buy
19,339
+5,349
+38% +$1.62M 0.17% 126
2019
Q3 		$4.08M Buy
13,990
+4,293
+44% +$1.23M 0.15% 139
2019
Q2 		$2.66M Buy
9,697
+1,678
+21% +$462K 0.1% 170
2019
Q1 		$2.19M Sell
8,019
-235
-3% -$58.5K 0.09% 206
2018
Q4 		$1.85M Sell
8,254
-490
-6% -$115K 0.08% 188
2018
Q3 		$2.13M Buy
8,744
+29
+0.3% +$6.67K 0.08% 214
2018
Q2 		$1.8M Buy
8,715
+79
+0.9% +$16.8K 0.08% 250
2018
Q1 		$1.78M Buy
8,636
+382
+5% +$80.2K 0.09% 235
2017
Q4 		$1.57M Buy
8,254
+364
+5% +$69.7K 0.08% 253
2017
Q3 		$1.49M Buy
7,890
+535
+7% +$96.9K 0.08% 237
2017
Q2 		$1.28M Buy
7,355
+253
+4% +$42.5K 0.08% 249
2017
Q1 		$1.09M Buy
7,102
+2,016
+40% +$308K 0.07% 246
2016
Q4 		$718K Buy
5,086
+586
+13% +$86.4K 0.05% 276
2016
Q3 		$716K Buy
4,500
+938
+26% +$145K 0.07% 250
2016
Q2 		$539K Buy
3,562
+671
+23% +$99K 0.06% 248
2016
Q1 		$409K Sell
2,891
-299
-9% -$40.1K 0.05% 299
2015
Q4 		$428K Buy
3,190
+593
+23% +$79.1K 0.05% 252
2015
Q3 		$318K Buy
2,597
+165
+7% +$21.5K 0.04% 251
2015
Q2 		$316K Sell
2,432
-574
-19% -$74.8K 0.04% 310
2015
Q1 		$404K Sell
3,006
-43
-1% -$5.54K 0.05% 275
2014
Q4 		$382K Sell
3,049
-11
-0.4% -$1.34K 0.04% 292
2014
Q3 		$372K Buy
3,060
+190
+7% +$23.1K 0.04% 320
2014
Q2 		$339K Buy
2,870
+784
+38% +$92.3K 0.03% 320
2014
Q1 		$251K Sell
2,086
-86
-4% -$10.2K 0.03% 389
2013
Q4 		$242K Sell
2,172
-27
-1% -$2.69K 0.02% 411
2013
Q3 		$203K Buy
+2,199
New +$199K 0.02% 434

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Atria Investments's TMO Position: Q1 2026 in Review

Atria Investments reduced its Thermo Fisher Scientific (TMO) stake by 12% in Q1 2026, selling an estimated $2.14M and leaving 28,478 shares worth $14M. The position accounts for 0.16% of the portfolio, ranked #129.

Atria Investments first reported a position in TMO in Q3 2013 and has held it in 50 quarters since. The position peaked at $30.5M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Atria Investments held 28,478 shares of Thermo Fisher Scientific worth $14M as of Q1 2026.
  • Atria Investments sold 3,943 Thermo Fisher Scientific shares in Q1 2026, an estimated $2.14M.
  • Thermo Fisher Scientific made up 0.16% of Atria Investments's portfolio in Q1 2026, its #129 holding.
  • Atria Investments first reported a position in Thermo Fisher Scientific in Q3 2013 and has held it in 50 quarters since.
  • Atria Investments's Thermo Fisher Scientific position peaked at $30.5M in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.